Alkermes PlcNASDAQ:ALKS
- LAST PRICE28.9700
- TODAY'S CHANGE (%)0.6000 (2.1149%)
- Bid / Lots28.9700/ 5
- Ask / Lots29.2300/ 1
- Open / Previous Close28.6700 / 28.3700
- Day Range
- 52 Week Range
- Volume1,124,266
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALKS |
|---|---|---|
| 09:32 ET | 5242 | 28.51 |
| 09:34 ET | 900 | 28.64 |
| 09:36 ET | 1307 | 28.635 |
| 09:38 ET | 1700 | 28.8 |
| 09:41 ET | 700 | 28.64 |
| 09:43 ET | 800 | 28.61 |
| 09:45 ET | 1908 | 28.69 |
| 09:48 ET | 1115 | 28.6994 |
| 09:50 ET | 100 | 28.63 |
| 09:52 ET | 1626 | 28.68 |
| 09:54 ET | 400 | 28.58 |
| 09:56 ET | 4050 | 28.545 |
| 09:57 ET | 1340 | 28.545 |
| 09:59 ET | 918 | 28.58 |
| 10:01 ET | 1100 | 28.545 |
| 10:03 ET | 3272 | 28.57 |
| 10:06 ET | 1600 | 28.59 |
| 10:10 ET | 1400 | 28.65 |
| 10:12 ET | 1300 | 28.595 |
| 10:14 ET | 907 | 28.6 |
| 10:15 ET | 500 | 28.61 |
| 10:17 ET | 1000 | 28.65 |
| 10:19 ET | 559 | 28.68 |
| 10:21 ET | 100 | 28.675 |
| 10:24 ET | 1300 | 28.625 |
| 10:26 ET | 900 | 28.575 |
| 10:28 ET | 3931 | 28.55 |
| 10:30 ET | 18502 | 28.5 |
| 10:32 ET | 2982 | 28.56 |
| 10:33 ET | 2627 | 28.585 |
| 10:35 ET | 1106 | 28.58 |
| 10:37 ET | 500 | 28.59 |
| 10:39 ET | 1600 | 28.59 |
| 10:42 ET | 1200 | 28.58 |
| 10:44 ET | 2558 | 28.58 |
| 10:46 ET | 3248 | 28.58 |
| 10:48 ET | 1435 | 28.58 |
| 10:50 ET | 800 | 28.58 |
| 10:51 ET | 500 | 28.63 |
| 10:53 ET | 2000 | 28.68 |
| 10:55 ET | 1268 | 28.69 |
| 10:57 ET | 500 | 28.7 |
| 11:00 ET | 1400 | 28.75 |
| 11:02 ET | 2010 | 28.735 |
| 11:04 ET | 300 | 28.73 |
| 11:06 ET | 1816 | 28.7197 |
| 11:08 ET | 200 | 28.7 |
| 11:09 ET | 100 | 28.66 |
| 11:11 ET | 3100 | 28.665 |
| 11:13 ET | 100 | 28.66 |
| 11:15 ET | 204 | 28.62 |
| 11:18 ET | 600 | 28.62 |
| 11:20 ET | 300 | 28.61 |
| 11:22 ET | 1973 | 28.57 |
| 11:24 ET | 3087 | 28.59 |
| 11:26 ET | 500 | 28.6 |
| 11:29 ET | 204 | 28.61 |
| 11:31 ET | 871 | 28.6098 |
| 11:33 ET | 562 | 28.59 |
| 11:36 ET | 2934 | 28.61 |
| 11:38 ET | 500 | 28.635 |
| 11:40 ET | 400 | 28.62 |
| 11:42 ET | 700 | 28.62 |
| 11:44 ET | 1400 | 28.61 |
| 11:45 ET | 300 | 28.59 |
| 11:47 ET | 100 | 28.58 |
| 11:49 ET | 800 | 28.58 |
| 11:51 ET | 1308 | 28.58 |
| 11:54 ET | 438 | 28.59 |
| 11:56 ET | 4484 | 28.6 |
| 11:58 ET | 200 | 28.6 |
| 12:00 ET | 200 | 28.6 |
| 12:02 ET | 793 | 28.62 |
| 12:03 ET | 1506 | 28.66 |
| 12:05 ET | 1513 | 28.7 |
| 12:07 ET | 992 | 28.72 |
| 12:09 ET | 500 | 28.72 |
| 12:12 ET | 500 | 28.735 |
| 12:14 ET | 200 | 28.7253 |
| 12:16 ET | 700 | 28.73 |
| 12:18 ET | 700 | 28.76 |
| 12:20 ET | 1800 | 28.75 |
| 12:21 ET | 100 | 28.755 |
| 12:23 ET | 1200 | 28.74 |
| 12:25 ET | 2444 | 28.68 |
| 12:27 ET | 2844 | 28.64 |
| 12:30 ET | 1300 | 28.665 |
| 12:32 ET | 2258 | 28.72 |
| 12:34 ET | 600 | 28.695 |
| 12:36 ET | 300 | 28.71 |
| 12:38 ET | 1075 | 28.74 |
| 12:39 ET | 1000 | 28.75 |
| 12:41 ET | 600 | 28.77 |
| 12:43 ET | 752 | 28.77 |
| 12:45 ET | 1472 | 28.77 |
| 12:48 ET | 200 | 28.77 |
| 12:50 ET | 2142 | 28.8 |
| 12:54 ET | 1794 | 28.77 |
| 12:56 ET | 1000 | 28.8 |
| 12:57 ET | 800 | 28.83 |
| 12:59 ET | 1100 | 28.8 |
| 01:01 ET | 400 | 28.81 |
| 01:03 ET | 1100 | 28.82 |
| 01:06 ET | 400 | 28.83 |
| 01:08 ET | 600 | 28.82 |
| 01:10 ET | 700 | 28.84 |
| 01:12 ET | 1100 | 28.865 |
| 01:14 ET | 1897 | 28.85 |
| 01:15 ET | 100 | 28.85 |
| 01:17 ET | 1303 | 28.85 |
| 01:19 ET | 1600 | 28.86 |
| 01:21 ET | 300 | 28.87 |
| 01:24 ET | 804 | 28.88 |
| 01:26 ET | 2032 | 28.87 |
| 01:28 ET | 300 | 28.87 |
| 01:30 ET | 782 | 28.9 |
| 01:32 ET | 1000 | 28.87 |
| 01:33 ET | 1700 | 28.89 |
| 01:35 ET | 1324 | 28.9 |
| 01:37 ET | 1726 | 28.87 |
| 01:39 ET | 800 | 28.85 |
| 01:42 ET | 712 | 28.86 |
| 01:44 ET | 1237 | 28.86 |
| 01:46 ET | 900 | 28.91 |
| 01:48 ET | 2289 | 28.88 |
| 01:50 ET | 200 | 28.875 |
| 01:51 ET | 1000 | 28.85 |
| 01:53 ET | 1573 | 28.83 |
| 01:55 ET | 400 | 28.83 |
| 01:57 ET | 1200 | 28.89 |
| 02:00 ET | 3623 | 28.875 |
| 02:02 ET | 300 | 28.87 |
| 02:04 ET | 1772 | 28.85 |
| 02:06 ET | 400 | 28.85 |
| 02:08 ET | 658 | 28.86 |
| 02:09 ET | 2100 | 28.87 |
| 02:11 ET | 200 | 28.87 |
| 02:13 ET | 4000 | 28.875 |
| 02:15 ET | 1969 | 28.86 |
| 02:18 ET | 3784 | 28.85 |
| 02:20 ET | 200 | 28.85 |
| 02:22 ET | 1837 | 28.8967 |
| 02:24 ET | 9640 | 28.9 |
| 02:26 ET | 519 | 28.92 |
| 02:27 ET | 1400 | 28.95 |
| 02:29 ET | 2185 | 28.93 |
| 02:31 ET | 1904 | 28.935 |
| 02:33 ET | 3689 | 28.88 |
| 02:36 ET | 1800 | 28.9 |
| 02:38 ET | 528 | 28.91 |
| 02:40 ET | 4170 | 28.92 |
| 02:42 ET | 2400 | 28.94 |
| 02:44 ET | 800 | 28.94 |
| 02:45 ET | 3053 | 28.95 |
| 02:47 ET | 1323 | 28.96 |
| 02:49 ET | 1500 | 28.97 |
| 02:51 ET | 3406 | 28.95 |
| 02:54 ET | 600 | 28.96 |
| 02:56 ET | 5027 | 28.95 |
| 02:58 ET | 2013 | 28.975 |
| 03:00 ET | 2386 | 28.97 |
| 03:02 ET | 49951 | 28.94 |
| 03:03 ET | 9360 | 28.935 |
| 03:05 ET | 522 | 28.935 |
| 03:07 ET | 4734 | 28.93 |
| 03:09 ET | 6002 | 28.975 |
| 03:12 ET | 2606 | 28.975 |
| 03:14 ET | 7069 | 28.965 |
| 03:16 ET | 28854 | 28.99 |
| 03:18 ET | 1000 | 28.99 |
| 03:20 ET | 10279 | 28.985 |
| 03:21 ET | 10600 | 29 |
| 03:23 ET | 8533 | 29.019 |
| 03:25 ET | 1973 | 29.025 |
| 03:27 ET | 6691 | 29.015 |
| 03:30 ET | 4392 | 29.02 |
| 03:32 ET | 4057 | 29 |
| 03:34 ET | 5019 | 28.995 |
| 03:36 ET | 8286 | 28.985 |
| 03:38 ET | 4719 | 29.009 |
| 03:39 ET | 1858 | 29.01 |
| 03:41 ET | 5949 | 29.009 |
| 03:43 ET | 9680 | 28.965 |
| 03:45 ET | 9321 | 28.97 |
| 03:48 ET | 6127 | 28.96 |
| 03:50 ET | 13152 | 28.91 |
| 03:52 ET | 2272 | 28.89 |
| 03:54 ET | 10051 | 28.905 |
| 03:56 ET | 13185 | 28.92 |
| 03:57 ET | 27249 | 28.94 |
| 03:59 ET | 247910 | 28.97 |
Sep 25, 2024
Alkermes to Host Investor Event to Review Orexin Portfolio Strategy, from 8:00AM ET on Wednesday Sep 25, 2024 by Dow Jones
8:00AM ET on Wednesday Sep 25, 2024 by Dow Jones
Sep 23, 2024
Sep 16, 2024
DJ Alkermes Price Target Maintained With a $48.00/Share by Cantor Fitzgerald, from 11:30AM ET on Monday Sep 16, 2024 by Dow Jones
11:30AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 13, 2024
Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards(R) Program, from 7:00AM ET on Friday Sep 13, 2024 by Dow Jones
7:00AM ET on Friday Sep 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alkermes Plc | 4.8B | 10.8x | --- |
Exelixis Inc | 7.6B | 22.8x | -21.77% |
PTC Therapeutics Inc | 2.7B | -5.6x | --- |
Ionis Pharmaceuticals Inc | 6.0B | -15.0x | --- |
Qiagen NV | 9.8B | 136.9x | +12.66% |
Novavax Inc | 2.2B | -4.9x | --- |
Company Information
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Contact Information
- Headquarters
- Connaught House 1 Burlington Road, Dublin 4DUBLIN, Ireland D04 C5Y6
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Richard Pops
- Interim Chief Financial Officer, Chief Operating Officer, Executive Vice President, Interim Chief Accounting Officer, Chief Risk Officer
- Blair Jackson
- Executive Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary
- David Gaffin
- Executive Vice President, Research and Development and Chief Medical Officer
- Craig Hopkinson
- Senior Vice President, Chief Commercial Officer
- C.Todd Nichols
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.8B |
|---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 164.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $2.67 |
Book Value | $7.20 |
P/E Ratio | 10.8x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | 9.4x |
Operating Margin | 24.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
